Biomodulatory Treatment With Azacitidine, All-trans Retinoic Acid and Pioglitazone Induces Differentiation of Primary AML Blasts Into Neutrophil Like Cells Capable of ROS Production and Phagocytosis

• Asıl Yazarlar: Sebastian Klobuch (Yazar), Tim Steinberg (Yazar), Emanuele Bruni (Yazar), Carina Mirbeth (Yazar), Bernhard Heilmeier (Yazar), Lina Ghibelli (Yazar), Wolfgang Herr (Yazar), Albrecht Reichle (Yazar), Simone Thomas (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2018-11-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Effective and tolerable salvage therapies for elderly patients with chemorefractory acute myeloid leukemia (AML) are limited and usually do not change the poor clinical outcome. We recently described in several chemorefractory elderly AML patients that a novel biomodulatory treatment regimen consist...